1st Quarter - Report

ARTEMIS STRATEGIES for TEVA PHARMACEUTICALS USA

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues relating to the US-Israel Trade USTR Special 301 Report

Foreign entity interest: Teva Pharmaceuticals USA is a wholly owned subsidiary of Teva Pharmaceuticals based in Israel

LobbyistCovered position, as disclosed
JOSEPH DAVIS —
DANA DEBEAUMONT New —
JAMES E DORNAN —
TIMOTHY F POWERS —
ARI STORCH —
ARI JONATHAN STRAUSS —
KATHERINE YEHL New —

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.